Skip to content

Anti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic Patients

Anti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic Patients

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00786500
Enrollment
24
Registered
2008-11-06
Start date
2007-02-28
Completion date
2007-12-31
Last updated
2010-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Herbal medicine, Type 2 diabetes, Insulin sensitivity, Insulin secretion

Brief summary

The aim of the present study was to investigate the long-term effects on blood glucose concentrations and possible adverse effects of an extract of Gynostemma pentaphyllum (GP). This is a plant growing in the mountain regions of Northern Vietnam and previously being used in traditional medicine. The GP extract, or placebo, was randomized to newly diagnosed patients with type 2 diabetes and administered as a tea, 3 g two times daily during 12 weeks. All patients received instructions regarding diet and physical exercise. Oral glucose tolerance tests were performed at baseline and then every 4 weeks, and blood tests were taken with the purpose to monitor lipids, kidney and liver function, body weight and blood pressure.

Detailed description

In Vietnam, herbal extracts have been used as a long-standing tradition to treat diabetic patients, but effects of these extracts have not been studied adequately. Based on previous results in experimental animals, we have selected the plant Gynostemma pentaphyllum (GP), which grows in the mountain region of Northern Vietnam. GP extract had a hypoglycemic effect on mice and rats, and was shown to contain a substance, phanoside, which stimulates insulin secretion. In addition, GP has been shown to reduce both hyperglycemia and hyperlipidemia in diabetic Zucker fatty rats. The present study aimed at investigate effects of GP extract, administered as a tea, and compared with placebo in a randomized, double-blind trial in drug-naive patients with newly diagnosed type 2 diabetes. All patients also received instructions about diet and physical exercise. In addition to monitoring effects on plasma glucose regulation, we also studied possible effects on plasma lipids, kidney and liver function as well as body weight and blood pressure.

Interventions

DIETARY_SUPPLEMENTGynostemma pentaphyllum tea

3 grams twice daily, orally

DIETARY_SUPPLEMENTPlacebo tea

3 grams twice daily, orally

Sponsors

Karolinska Institutet
CollaboratorOTHER
Swedish International Development Cooperation Agency (SIDA)
CollaboratorOTHER_GOV
Hanoi Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Newly diagnosed, drug-naive patients with type 2 diabetes * Fasting plasma glucose (FPG) 7.0-14.0 mmol/l * HbA1c \> 6%

Exclusion criteria

* Type 1 diabetes * Liver failure * Kidney Failure

Design outcomes

Primary

MeasureTime frame
Fasting plasma glucose12 weeks
HbA1c (glycosylated hemoglobin)12 weeks

Secondary

MeasureTime frame
Plasma lipids (TG, Cholesterol, HDL-, LDL-)12 weeks
Liver enzymes (ALT, AST)12 weeks
Body weight (BMI, hip-waist ratio)12 weeks
Blood pressure12 weeks
Kidney function (S-creatinine, S-BUN)12 weeks

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026